-
721
Evidence of Carotid Atherosclerosis Vulnerability Regression in Real Life From Magnetic Resonance Imaging: Results of the MAGNETIC Prospective Study
Published 2023-01-01“…We aimed to demonstrate vulnerability regression in real life, with a comprehensive quantitative method, in patients with asymptomatic mild to moderate carotid atherosclerosis on a secondary prevention program. …”
Get full text
Article -
722
-
723
Hematologic toxicity of radium-223 in elderly patients with metastatic Castration Resistant Prostate Cancer: a real-life experience
Published 2019-03-01“…Materials and methods: We evaluated the hematologic toxicity of Ra-223 treatment in a real-life experience of 38 patients from two Italian cancer centers, with bone metastases from mCRPC. …”
Get full text
Article -
724
-
725
-
726
Effectiveness of the Use of Three-Dose Intravitreal Ziv-Aflibercept in the Management of Diabetic Macular Edema in a Real-Life Setting
Published 2023-04-01“…The objective of this study was to evaluate in a real-life setting, the efficacy of intravitreal Ziv-aflibercept in the treatment of DME after the administration of three consecutive monthly doses.Methods: A single arm, prospective cohort study. …”
Get full text
Article -
727
Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy
Published 2023-12-01“…Background Long-term real-life data on secukinumab use in psoriasis are limited. …”
Get full text
Article -
728
Risankizumab Therapy for Moderate-to-Severe Psoriasis—A Multi-Center, Long-Term, Real-Life Study from Poland
Published 2023-02-01Subjects: Get full text
Article -
729
-
730
Acceptance of Automated Shuttles—Application and Extension of the UTAUT-2 Model to Wizard-of-Oz Automated Driving in Real-Life Traffic
Published 2022-12-01“…Here, we employed the UTAUT-2 to assess acceptance of a Wizard-of-Oz automated shuttle in real-life traffic, in a study with 35 participants, before and after a first ride and after a second ride on which two incidents occurred. …”
Get full text
Article -
731
-
732
Brolucizumab Intravitreal Injections for Wet Age-Related Macular Degeneration: Real-Life Study on a Cohort of Italian Patients
Published 2023-06-01“…<i>Background and Objectives:</i> To report the real-life Brolucizumab therapeutical outcomes of treatment-naïve and non-treatment-naïve eyes with neovascular age-related macular degeneration (nAMD) and to analyze the incidence of therapy-related adverse events. …”
Get full text
Article -
733
Measurable Residual Disease in Chronic Lymphocytic Leukemia: Experience in Real-Life Setting with Dry Tube Flow Cytometric Method
Published 2022-06-01“…In the patients studied with the dry tube method, the median PFS of the ones who achieved uMRD was also significantly longer than those who did not.Conclusion:Our study has indicated that flow cytometry based MRD surveillance of CLL patients in real-life setting provides prognostic information regarding PFS in accordance with clinical studies. …”
Get full text
Article -
734
'Real-life' benefit of hearing preservation cochlear implantation in the paediatric population: a single-site case–control study
Published 2023-05-01“…The combination of electrical hearing with either preserved acoustic hearing or amplified ‘natural’ hearing has the potential to address these issues and enable children with HPCI to closely follow normal auditory development.The aim of this study is to evaluate the ‘real-life’ benefit of preserved acoustic low-frequency hearing in children with a CI, understand the benefits of preserved natural hearing in complex listening situations and so enable parents and children to make an informed choice about implantation. …”
Get full text
Article -
735
Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life
Published 2024-04-01“… Although the use of prophylaxis regimens with prolonged half-life factors is now widespread in the world of hemophilia A, there is a lack of real-life evidence on the impact of these products on joint health, adherence, and quality of life of patients. …”
Get full text
Article -
736
-
737
-
738
-
739
Risankizumab for the Treatment of the Patients with Moderate to Severe Plaque Psoriasis During a 24-Week Period: Real-Life Experience
Published 2023-12-01“…However, long-term studies, including more extensive patient series, are needed to validate its efficacy and safety in real-life clinical settings.Keywords: psoriasis, risankizumab, anti-IL 23…”
Get full text
Article -
740